SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001193125-17-255045
Filing Date
2017-08-11
Accepted
2017-08-11 06:08:17
Documents
7

Document Format Files

Seq Description Document Type Size
1 424B3 d418022d424b3.htm 424B3 3287952
2 GRAPHIC g418022g03y27.jpg GRAPHIC 58125
3 GRAPHIC g418022g15i39.jpg GRAPHIC 63526
4 GRAPHIC g418022g31a22.jpg GRAPHIC 22177
5 GRAPHIC g418022g32c63.jpg GRAPHIC 59343
6 GRAPHIC g418022g66w40.jpg GRAPHIC 52942
7 GRAPHIC g418022g95c60.jpg GRAPHIC 82970
  Complete submission text file 0001193125-17-255045.txt   3757057
Mailing Address 2635 TECHNOLOGY FOREST BLVD. THE WOODLANDS TX 77381
Business Address 2635 TECHNOLOGY FOREST BLVD. THE WOODLANDS TX 77381 (281) 272-9331
Opexa Therapeutics, Inc. (Filer) CIK: 0001069308 (see all company filings)

IRS No.: 760333165 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-219358 | Film No.: 171022909
SIC: 2834 Pharmaceutical Preparations